Kura Oncology(KURA),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community - To The Moon

At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.

Close

KURA Kura Oncology

Market Closed 03-27 16:00:00 EDT

7.74

-0.62

-7.42%

盘后7.70

-0.04-0.52%

18:28 EDT

High8.39	Low7.73	Vol2.20M
Open8.32	D1 Closing8.36	Amplitude7.83%
Mkt Cap683.67M	Tradable Cap495.25M	Total Shares88.33M
T/O17.35M	T/O Rate3.43%	Tradable Shares63.99M
P/B--	ROE--	EPS0.00
52wk High--	52wk Low--	P/E--
Dividend--	Div.Yield--	ROA--

Loading ...

{"stockData":{"symbol":"KURA","market":"US","secType":"STK","nameCN":"Kura Oncology","latestPrice":7.74,"timestamp":1774641600000,"preClose":8.36,"halted":0,"volume":2197072,"hourTrading":{"tag":"盘后","latestPrice":7.7,"preClose":7.74,"latestTime":"18:28 EDT","volume":219357,"amount":1697976.19,"timestamp":1774650527551,"change":-0.04,"changeRate":-0.005168,"amplitude":0.024548},"delay":0,"changeRate":-0.07416267942583724,"floatShares":63985582,"shares":88329800,"eps":-3.178361,"marketStatus":"Market Closed","change":-0.62,"latestTime":"03-27 16:00:00 EDT","open":8.32,"high":8.385,"low":7.73,"amount":17348024.7063712,"amplitude":0.078349,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-3.178361,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1774857600000},"marketStatusCode":7,"adr":0,"adrRate":0,"listingDate":1446699600000,"exchange":"NASDAQ","adjPreClose":8.36,"postHourTrading":{"tag":"盘后","latestPrice":7.7,"preClose":7.74,"latestTime":"18:28 EDT","volume":219357,"amount":1697976.19,"timestamp":1774650527551,"change":-0.04,"changeRate":-0.005168,"amplitude":0.024548},"volumeRatio":1.5019580054097728,"impliedVol":0.6524,"impliedVolPercentile":0.3546},"requestUrl":"/m/hq/s/KURA","defaultTab":"news","newsList":[{"id":"2622224660","title":"Kura Oncology Inc : Mizuho Cuts Target Price to $25 From $30","url":"https://stock-news.laohu8.com/highlight/detail?id=2622224660","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2622224660?lang=en_us&edition=fundamental","pubTime":"2026-03-25 18:34","pubTimestamp":1774434890,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260325:nFWN40D0PQ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","KURA","BK4505"],"gpt_icon":0},{"id":"2622947850","title":"Kura Oncology Is Maintained at Outperform by Mizuho","url":"https://stock-news.laohu8.com/highlight/detail?id=2622947850","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2622947850?lang=en_us&edition=fundamental","pubTime":"2026-03-25 01:21","pubTimestamp":1774372860,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/KURA/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  March 24, 2026 13:21 ET (17:21 GMT)","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":"8603dabb40994e59ac78c04c930c0d49","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["KURA","MFG"],"gpt_icon":0},{"id":"2621096495","title":"Kura Oncology price target lowered to $25 from $30 at Mizuho","url":"https://stock-news.laohu8.com/highlight/detail?id=2621096495","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2621096495?lang=en_us&edition=fundamental","pubTime":"2026-03-24 23:07","pubTimestamp":1774364831,"startTime":"0","endTime":"0","summary":"Mizuho analyst Salim Syed lowered the firm’s price target on Kura Oncology (KURA) to $25 from $30 and keeps an Outperform rating on the shares. The...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/kura-oncology-price-target-lowered-to-25-from-30-at-mizuho-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/kura-oncology-price-target-lowered-to-25-from-30-at-mizuho-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["MFG","KURA"],"gpt_icon":0},{"id":"2619314861","title":"Kura Oncology Is Maintained at Buy by UBS","url":"https://stock-news.laohu8.com/highlight/detail?id=2619314861","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2619314861?lang=en_us&edition=fundamental","pubTime":"2026-03-14 04:37","pubTimestamp":1773434220,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/KURA/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  March 13, 2026 16:37 ET (20:37 GMT)","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["KURA"],"gpt_icon":0},{"id":"2619113101","title":"UBS Trims Price Target on Kura Oncology to $15 From $16, Maintains Buy Rating","url":"https://stock-news.laohu8.com/highlight/detail?id=2619113101","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2619113101?lang=en_us&edition=fundamental","pubTime":"2026-03-13 22:15","pubTimestamp":1773411303,"startTime":"0","endTime":"0","summary":"Kura Oncology (KURA) has an average rating of buy and mean price target of $32.36, according to analysts polled by FactSet.(MT Newswires covers equity, commodity and economic research from major banks","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["KURA"],"gpt_icon":0},{"id":"2619118768","title":"Kura Oncology price target lowered to $15 from $16 at UBS","url":"https://stock-news.laohu8.com/highlight/detail?id=2619118768","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2619118768?lang=en_us&edition=fundamental","pubTime":"2026-03-13 21:43","pubTimestamp":1773409400,"startTime":"0","endTime":"0","summary":"UBS analyst David Dai lowered the firm’s price target on Kura Oncology (KURA) to $15 from $16 and keeps a Buy rating on the shares. Published first...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/kura-oncology-price-target-lowered-to-15-from-16-at-ubs-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/kura-oncology-price-target-lowered-to-15-from-16-at-ubs-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["KURA"],"gpt_icon":0},{"id":"2617650401","title":"Kura Oncology (KURA) Receives a Hold from Guggenheim","url":"https://stock-news.laohu8.com/highlight/detail?id=2617650401","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2617650401?lang=en_us&edition=fundamental","pubTime":"2026-03-07 21:46","pubTimestamp":1772891207,"startTime":"0","endTime":"0","summary":"In a report released yesterday, from Guggenheim maintained a Hold rating on Kura Oncology. The company’s shares closed yesterday at $8.96. In addit...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/kura-oncology-kura-receives-a-hold-from-guggenheim-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/kura-oncology-kura-receives-a-hold-from-guggenheim-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["KURA","BK4505","BK4139"],"gpt_icon":0},{"id":"2617633968","title":"Kura Oncology Is Maintained at Outperform by Wedbush","url":"https://stock-news.laohu8.com/highlight/detail?id=2617633968","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2617633968?lang=en_us&edition=fundamental","pubTime":"2026-03-06 21:59","pubTimestamp":1772805540,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/KURA/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  March 06, 2026 08:59 ET (13:59 GMT)","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["KURA"],"gpt_icon":0},{"id":"2617680393","title":"Kura Oncology reports inducement grants under Nasdaq listing rule","url":"https://stock-news.laohu8.com/highlight/detail?id=2617680393","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2617680393?lang=en_us&edition=fundamental","pubTime":"2026-03-06 20:36","pubTimestamp":1772800574,"startTime":"0","endTime":"0","summary":"Kura Oncology (KURA) announced that on March 2, 2026, the Compensation Committee of the Company’s Board of Directors granted inducement awards cons...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/kura-oncology-reports-inducement-grants-under-nasdaq-listing-rule-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/kura-oncology-reports-inducement-grants-under-nasdaq-listing-rule-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4505","NQmain","BK4139","KURA"],"gpt_icon":0},{"id":"2617687246","title":"BRIEF-Kura Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)","url":"https://stock-news.laohu8.com/highlight/detail?id=2617687246","media":"Reuters","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2617687246?lang=en_us&edition=fundamental","pubTime":"2026-03-06 20:30","pubTimestamp":1772800236,"startTime":"0","endTime":"0","summary":"BRIEF-Kura Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)March 6 (Reuters) - Kura Oncology Inc KURA.O:KURA ONCOLOGY REPORTS INDUCEMENT GRANTS UNDER NASDAQ LISTING RULE 5635(C)","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260306:nTUA5FKRW1:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["KURA","BK4139","BK4505"],"gpt_icon":0},{"id":"2617868708","title":"Kura Oncology Reports Inducement Stock Option Grants for Four New Employees","url":"https://stock-news.laohu8.com/highlight/detail?id=2617868708","media":"Reuters","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2617868708?lang=en_us&edition=fundamental","pubTime":"2026-03-06 20:30","pubTimestamp":1772800215,"startTime":"0","endTime":"0","summary":"Kura Oncology said its board compensation committee granted inducement awards to four new employees consisting of nonstatutory stock options to buy a total of 44,700 common shares under its amended 2023 Inducement Option Plan. The options carry an exercise price of $8.68 per share and vest over four years, with 25% vesting after one year and the remainder vesting monthly over the following 36 months, subject to continued service.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260306:nNDL2mNrPk:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00BKPKM429.USD","BK4588","BK4505","IE00B64PRP62.GBP","NDAQ","IE00BGHQF748.EUR","SG9999014013.SGD","KURA","LU0314104364.USD","LU2210150020.SGD","LU2095319765.USD","SG9999014039.USD","IE00B3QW5Z07.USD","BK4139","SG9999014021.USD","BK4112","LU2210149790.SGD","SG9999014005.SGD","BK4585"],"gpt_icon":0},{"id":"2617268430","title":"Analysts Conflicted on These Healthcare Names: Atea Pharmaceuticals (AVIR), InnovAge Holding (INNV) and Kura Oncology (KURA)","url":"https://stock-news.laohu8.com/highlight/detail?id=2617268430","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2617268430?lang=en_us&edition=fundamental","pubTime":"2026-03-06 18:51","pubTimestamp":1772794299,"startTime":"0","endTime":"0","summary":"Analysts have been eager to weigh in on the Healthcare sector with new ratings on Atea Pharmaceuticals (AVIR – Research Report), InnovAge Holding (...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-conflicted-on-these-healthcare-names-atea-pharmaceuticals-avir-innovage-holding-innv-and-kura-oncology-kura-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-conflicted-on-these-healthcare-names-atea-pharmaceuticals-avir-innovage-holding-innv-and-kura-oncology-kura-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","HCSG","BK4007","BK4505","BK4581","INNV","KURA","BK4137","LABU","LU0029874061.USD","XBI","XLV","BK4588","LU0128526141.USD","BK4585","BK4196","AVIR"],"gpt_icon":0},{"id":"2617574720","title":"Analysts Offer Insights on Healthcare Companies: RegenXBio (RGNX) and Kura Oncology (KURA)","url":"https://stock-news.laohu8.com/highlight/detail?id=2617574720","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2617574720?lang=en_us&edition=fundamental","pubTime":"2026-03-06 06:40","pubTimestamp":1772750407,"startTime":"0","endTime":"0","summary":"There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on RegenXBio (RGNX – Research Report) and Kura Oncology...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-regenxbio-rgnx-and-kura-oncology-kura-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-regenxbio-rgnx-and-kura-oncology-kura-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4588","KURA","RGNX","BK4137","BK4585","XBI","XLV","BK4139","HCSG","LU0128526141.USD","BK4581","BK4505","BK4563","LABU","LU0029874061.USD"],"gpt_icon":0},{"id":"2617578412","title":"Wedbush Cuts Kura Oncology Price Target to $36 From $38, Outperform Rating Maintained","url":"https://stock-news.laohu8.com/highlight/detail?id=2617578412","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2617578412?lang=en_us&edition=fundamental","pubTime":"2026-03-06 03:23","pubTimestamp":1772738625,"startTime":"0","endTime":"0","summary":"Kura Oncology (KURA) has an average rating of Buy and mean price target of $31.45, according to analysts polled by FactSet.(MT Newswires covers equity, commodity and economic research from major banks","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["KURA"],"gpt_icon":0},{"id":"2617273655","title":"Kura Oncology: Early KOMZIFTI Launch Momentum, Robust AML Data, and Strong Cash Runway Underpin Buy Rating","url":"https://stock-news.laohu8.com/highlight/detail?id=2617273655","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2617273655?lang=en_us&edition=fundamental","pubTime":"2026-03-06 01:35","pubTimestamp":1772732130,"startTime":"0","endTime":"0","summary":"Joseph Pantginis, an analyst from H.C. Wainwright, reiterated the Buy rating on Kura Oncology. The associated price target remains the same with $4...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/ratings/kura-oncology-early-komzifti-launch-momentum-robust-aml-data-and-strong-cash-runway-underpin-buy-rating-ratings-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/ratings/kura-oncology-early-komzifti-launch-momentum-robust-aml-data-and-strong-cash-runway-underpin-buy-rating-ratings-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["KURA"],"gpt_icon":0},{"id":"2617523053","title":"Kura Oncology Publishes Corporate Presentation on KOMZIFTI Launch and Precision Oncology Pipeline","url":"https://stock-news.laohu8.com/highlight/detail?id=2617523053","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2617523053?lang=en_us&edition=fundamental","pubTime":"2026-03-05 22:21","pubTimestamp":1772720503,"startTime":"0","endTime":"0","summary":"Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Kura Oncology Inc. published the original content used to generate this news brief on March 05, 2026, and is solely responsible for the information contained therein.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260305:nNDL5G0t7p:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["KURA","BK4505","BK4139"],"gpt_icon":0},{"id":"2617941523","title":"BUZZ-U.S. STOCKS ON THE MOVE -Burlington Stores, Berkshire Hathaway, Bioventus","url":"https://stock-news.laohu8.com/highlight/detail?id=2617941523","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2617941523?lang=en_us&edition=fundamental","pubTime":"2026-03-05 22:13","pubTimestamp":1772720003,"startTime":"0","endTime":"0","summary":"BUZZ-U.S. STOCKS ON THE MOVE -Burlington Stores, Berkshire Hathaway, BioventusEikon search string for individual stock moves: STXBZThe Day Ahead newsletter: https://refini.tv/3LI4BU7The Morning News C","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260305:nL6N3ZT0RB:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["FDX","XYZ","LII","RGTX","BARC.UK","XYZG","AFRU","AVGG","KR","KURA","PYPG","BK4096","BTAI","LU2896262040.SGD","MDLN","GO","PYPY","LU2237438978.USD","BURL","RTX","TTDU","BJ","LU0672654240.SGD","AVGX","RTXG","AVS","LU0203345920.USD","VSCO","AFRM","RGTU","FTCI","LU0708995401.HKD","RGTZ","KLAR","RGYY","SHC","PSA","AVGU","INVH","AVL","STUB","AVGW","VEEV","BVS","XYZY"],"gpt_icon":1},{"id":"2617540200","title":"BUZZ-Kura falls after downbeat fourth-quarter results","url":"https://stock-news.laohu8.com/highlight/detail?id=2617540200","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2617540200?lang=en_us&edition=fundamental","pubTime":"2026-03-05 21:35","pubTimestamp":1772717719,"startTime":"0","endTime":"0","summary":"BUZZ-Kura falls after downbeat fourth-quarter results** Shares of drugmaker Kura Oncology KURA.O fall 5.80% to $8.05 premarket ** Co posts Q4 loss of 92 cents per share, while analysts were expecting a loss of 61 cents per share, according to data compiled by LSEG ** Posts Q4 revenue of $17.3 million, below analysts'  estimate of $53.6 million ** R&D expenses for the quarter were $64.4 million, tied to  advancement of combination trials for its blood cancer drug, ziftomenib - KURA ** KURA shares had risen over 19% in 2025  ","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260305:nL4N3ZT0YW:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","BK4505","KURA"],"gpt_icon":0},{"id":"2617754995","title":"Kura Oncology reports Q4 EPS (92c), consensus (49c)","url":"https://stock-news.laohu8.com/highlight/detail?id=2617754995","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2617754995?lang=en_us&edition=fundamental","pubTime":"2026-03-05 19:36","pubTimestamp":1772710565,"startTime":"0","endTime":"0","summary":"Reports Q4 revenue $17.34M, consensus $35.45M. As of December 31, 2025, Kura had $667.2M in cash, cash equivalents and short-term investments, comp...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/kura-oncology-reports-q4-eps-92c-consensus-49c-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/kura-oncology-reports-q4-eps-92c-consensus-49c-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["KURA"],"gpt_icon":0},{"id":"2617549332","title":"Earnings Flash (KURA) Kura Oncology Posts Q4 Loss $0.92 a Share, vs. FactSet Est of $0.64 Loss","url":"https://stock-news.laohu8.com/highlight/detail?id=2617549332","media":"MT Newswires Live","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2617549332?lang=en_us&edition=fundamental","pubTime":"2026-03-05 19:36","pubTimestamp":1772710563,"startTime":"0","endTime":"0","summary":"Earnings Flash (KURA) Kura Oncology Posts Q4 Loss $0.92 a Share, vs. FactSet Est of $0.64 Loss","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["KURA"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.kuraoncology.com","stockEarnings":[{"period":"1week","weight":-0.063},{"period":"1month","weight":-0.0958},{"period":"3month","weight":-0.2719},{"period":"6month","weight":-0.1448},{"period":"1year","weight":0.084},{"period":"ytd","weight":-0.2551}],"compareEarnings":[{"period":"1week","weight":-0.0223},{"period":"1month","weight":-0.0852},{"period":"3month","weight":-0.0814},{"period":"6month","weight":-0.0419},{"period":"1year","weight":0.1182},{"period":"ytd","weight":-0.0701}],"compareStock":{"symbol":"SPY","name":"SPDR S&P 500 ETF Trust"},"description":"Kura Oncology, Inc., a clinical-stage biopharmaceutical company, develops medicines for the treatment of cancer. The company's pipeline consists of small molecule product candidates that target cancer. Its lead product candidates are ziftomenib, an orally bioavailable small molecule inhibitor of the menin-KMT2A interaction for the treatment of genetically defined subsets of acute leukemias, including acute myeloid leukemia and acute lymphoblastic leukemia; tipifarnib, an orally bioavailable farnesyl transferase inhibitor combination with alpelisib for patients with PIK3CA-dependent HNSCC; and KO-2806, a farnesyl transferase inhibitor for the treatment of solid tumors. It has a clinical collaboration with Novartis Pharma AG to evaluate the combination of tipifarnib and alpelisib in patients with head and neck squamous cell carcinoma whose tumors have HRAS overexpression and/or PIK3CA mutation and/or amplification. The company was founded in 2014 and is headquartered in San Diego, California.","yearOnYearQuotes":[{"month":1,"riseRate":0.545455,"avgChangeRate":0.002309},{"month":2,"riseRate":0.545455,"avgChangeRate":0.031825},{"month":3,"riseRate":0.545455,"avgChangeRate":-0.037486},{"month":4,"riseRate":0.2,"avgChangeRate":-0.031764},{"month":5,"riseRate":0.5,"avgChangeRate":0.015121},{"month":6,"riseRate":0.5,"avgChangeRate":0.037607},{"month":7,"riseRate":0.5,"avgChangeRate":0.037366},{"month":8,"riseRate":0.5,"avgChangeRate":0.066679},{"month":9,"riseRate":0.5,"avgChangeRate":0.12103},{"month":10,"riseRate":0.3,"avgChangeRate":-0.077132},{"month":11,"riseRate":0.8,"avgChangeRate":0.052179},{"month":12,"riseRate":0.454545,"avgChangeRate":0.00367}],"exchange":"NASDAQ","name":"Kura Oncology","nameEN":"Kura Oncology"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.38.0","shortVersion":"4.38.0","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Kura Oncology(KURA),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest Kura Oncology(KURA) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"Kura Oncology,KURA,Kura Oncology股票,Kura Oncology股票老虎,Kura Oncology股票老虎国际,Kura Oncology行情,Kura Oncology股票行情,Kura Oncology股价,Kura Oncology股市,Kura Oncology股票价格,Kura Oncology股票交易,Kura Oncology股票购买,Kura Oncology股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Kura Oncology(KURA),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest Kura Oncology(KURA) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}